Quarterly report pursuant to Section 13 or 15(d)

SUPPLEMENTAL CASH FLOW INFORMATION

v3.8.0.1
SUPPLEMENTAL CASH FLOW INFORMATION
9 Months Ended
Sep. 30, 2017
Supplemental Cash Flow Information [Abstract]  
SUPPLEMENTAL CASH FLOW INFORMATION

NOTE 4 – SUPPLEMENTAL CASH FLOW INFORMATION

 

The following table contains additional information for the periods reported (in thousands).

 

    Nine Months Ended September 30,  
    2017     2016  
Non-cash financial activities:                
Derivative liability issued     4,604        
Preferred stock and warrants issued for fees     5        
Net assets and liabilities recognized with the acquisition of Lewis and Clark Pharmaceuticals, Inc.     2,493        
Accounts payable paid through issuance of debentures     70        
Debentures issued to retire preferred stock     2,504        
Debentures converted to common stock     38        

 

There was no cash paid for interest and income taxes for the nine months ended September 30, 2017 and 2016.